Listen Now
Topics Covered
- Overview & Definition of Diagnostic Technologies for Small Cell Lung Cancer
- How Diagnostic Technologies Work
- Examples of How Diagnostic Technologies Inform the Treatment of Small Cell Lung Cancer
- Understanding the FDA’s Accelerated Approval Program: How It Increases Your Treatment Options
- Combination Systemic Treatment for Metastatic Small Cell Lung Cancer
- Diagnostic Technologies, Targeted Therapies & Precision Medicine
- The Role of the Pathologist
- OpenNotes - Asking Your Healthcare Team & Pathologist to Help You Understand OpenNotes
- Clinical Trials: How Diagnostic Technology Research Contributes to Treatment Choices
- The Benefits of Combination Therapy in the Treatment of People Living with SCLC
- Talking with Your Healthcare Team about the Most Current Treatment Choices for SCLC & Quality-of-Life Issues
- Guidelines to Prepare for Telehealth/Telemedicine Appointments, including Technology, Prepared List of Questions, Follow-Up Appointment
- Questions for Our Panel of Experts
Our Panel of Experts

Nasser H. Hanna, MD
Tom and Julie Wood Family Foundation Professor of Lung Cancer Clinical Research, Professor of Medicine, Vice-Chief Oncology and Malignant Hematology, Service Line Leader, Hematology/Oncology, Indiana University School of Medicine

Brian S. Henick, MD
Assistant Professor of Medicine at CUMC, Associate Director, Experimental Therapeutics, Thoracic Oncology, Herbert Irving Comprehensive Cancer Center

Benjamin J. Swanson, MD, PhD
Associate Professor of Pathology & Microbiology, Surgical Pathologist Specializing in Lung, Head & Neck and GI Diseases, University of Nebraska Medical Center

Nikole Ventrca
Senior Support Services Manager, LUNGevity Foundation

Carolyn Messner, DSW, BCD, FAPOS, FAOSW
Senior Director of Education and Training, CancerCare
Brochure
You can download the brochure for this workshop
Workshop Date
This workshop was originally recorded on June 28, 2022.